Home LiteratureArticle Details
PMID: 11158315 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.

Molecular and cellular biology ·Vol. 21 ·No. 4 ·2001-02-00 ·Pages 1297-310

Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A

Abstract

Hypoxic stress, like DNA damage, induces p53 protein accumulation and p53-dependent apoptosis in oncogenically transformed cells. Unlike DNA damage, hypoxia does not induce p53-dependent cell cycle arrest, suggesting that p53 activity is differentially regulated by these two stresses. Here we report that hypoxia induces p53 protein accumulation, but in contrast to DNA damage, hypoxia fails to induce endogenous downstream p53 effector mRNAs and proteins. Hypoxia does not inhibit the induction of p53 target genes by ionizing radiation, indicating that p53-dependent transactivation requires a DNA damage-inducible signal that is lacking under hypoxic treatment alone. At the molecular level, DNA damage induces the interaction of p53 with the transcriptional activator p300 as well as with the transcriptional corepressor mSin3A. In contrast, hypoxia primarily induces an interaction of p53 with mSin3A, but not with p300. Pretreatment of cells with an inhibitor of histone deacetylases that relieves transcriptional repression resulted in a significant reduction of p53-dependent transrepression and hypoxia-induced apoptosis. These results led us to propose a model in which different cellular pools of p53 can modulate transcriptional activity through interactions with transcriptional coactivators or corepressors. Genotoxic stress induces both kinds of interactions, whereas stresses that lack a DNA damage component as exemplified by hypoxia primarily induce interaction with corepressors. However, inhibition of either type of interaction can result in diminished apoptotic activity.

MeSH Terms
Acetylation Apoptosis/genetics,physiology Binding Sites Cell Hypoxia/genetics,physiology Cell Line Cell Nucleus/metabolism Cell Transformation, Neoplastic DNA Damage Genes, p53 Histone Deacetylase Inhibitors Histone Deacetylases/metabolism Humans Models, Biological Nuclear Proteins Phosphorylation Proto-Oncogene Proteins/genetics,metabolism Proto-Oncogene Proteins c-mdm2 RNA, Messenger/genetics,metabolism Signal Transduction Transcriptional Activation Tumor Suppressor Protein p53/chemistry,genetics,metabolism
Chemicals
Histone Deacetylase Inhibitors Nuclear Proteins Proto-Oncogene Proteins RNA, Messenger Tumor Suppressor Protein p53 MDM2 protein, human Proto-Oncogene Proteins c-mdm2 Histone Deacetylases
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Koumenis C
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305, USA.
Alarcon R
Hammond E
Sutphin P
Hoffman W
Murphy M
Derr J
Taya Y
Lowe S W
Kastan M
Giaccia A
References (55)
55 references, click to expand
  1. The comet assay: a comprehensive review.
    Mutat Res. 1995 Feb;339(1):37-59 PMID: 7877644
  2. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Cell. 1995 Jan 27;80(2):293-9 PMID: 7834749
  3. Negative feedback regulation of wild-type p53 biosynthesis.
    EMBO J. 1995 Sep 15;14(18):4442-9 PMID: 7556087
  4. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53.
    Oncogene. 1995 Dec 7;11(11):2197-205 PMID: 8570169
  5. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
    Nature. 1996 Jan 4;379(6560):88-91 PMID: 8538748
  6. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.
    Genes Dev. 1996 May 15;10(10):1219-32 PMID: 8675009
  7. Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo.
    Mol Cell Biol. 1996 Aug;16(8):4295-304 PMID: 8754830
  8. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.
    Genes Dev. 1996 Oct 1;10(19):2438-51 PMID: 8843196
  9. Wild-type p53 negatively regulates the expression of a microtubule-associated protein.
    Genes Dev. 1996 Dec 1;10(23):2971-80 PMID: 8956998
  10. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation.
    Mol Cell Biol. 1997 Jan;17(1):355-63 PMID: 8972216
  11. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  12. Mdm2 promotes the rapid degradation of p53.
    Nature. 1997 May 15;387(6630):296-9 PMID: 9153395
  13. Regulation of p53 stability by Mdm2.
    Nature. 1997 May 15;387(6630):299-303 PMID: 9153396
  14. Synergistic activation of transcription by CBP and p53.
    Nature. 1997 Jun 19;387(6635):819-23 PMID: 9194564
  15. Binding and modulation of p53 by p300/CBP coactivators.
    Nature. 1997 Jun 19;387(6635):823-7 PMID: 9194565
  16. Recruitment of p300/CBP in p53-dependent signal pathways.
    Cell. 1997 Jun 27;89(7):1175-84 PMID: 9215639
  17. The polyproline region of p53 is required to activate apoptosis but not growth arrest.
    Oncogene. 1997 Aug 18;15(8):887-98 PMID: 9285684
  18. Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway.
    J Biol Chem. 1997 Sep 12;272(37):23435-9 PMID: 9287359
  19. A model for p53-induced apoptosis.
    Nature. 1997 Sep 18;389(6648):300-5 PMID: 9305847
  20. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
    Cell. 1997 Oct 31;91(3):325-34 PMID: 9363941
  21. DNA damage induces phosphorylation of the amino terminus of p53.
    Genes Dev. 1997 Dec 15;11(24):3471-81 PMID: 9407038
  22. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3519-24 PMID: 9520398
  23. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
    Cancer Res. 1998 Apr 1;58(7):1408-16 PMID: 9537241
  24. Identification of a novel p53 functional domain that is necessary for mediating apoptosis.
    J Biol Chem. 1998 May 22;273(21):13030-6 PMID: 9582339
  25. Multisite phosphorylation and the integration of stress signals at p53.
    Cell Signal. 1998 Mar;10(3):159-66 PMID: 9607138
  26. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest.
    Mol Cell Biol. 1998 Jul;18(7):3692-8 PMID: 9632751
  27. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression.
    Nat Med. 1998 Jul;4(7):835-8 PMID: 9662377
  28. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
    EMBO J. 1998 Aug 17;17(16):4668-79 PMID: 9707426
  29. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
    Science. 1998 Sep 11;281(5383):1677-9 PMID: 9733515
  30. DNA damage activates p53 through a phosphorylation-acetylation cascade.
    Genes Dev. 1998 Sep 15;12(18):2831-41 PMID: 9744860
  31. The complexity of p53 modulation: emerging patterns from divergent signals.
    Genes Dev. 1998 Oct 1;12(19):2973-83 PMID: 9765199
  32. Signaling to p53: breaking the MDM2-p53 circuit.
    Cell. 1998 Oct 2;95(1):5-8 PMID: 9778240
  33. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
    J Exp Med. 1998 Dec 7;188(11):2033-45 PMID: 9841917
  34. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
    Genes Dev. 1999 Jan 1;13(1):64-75 PMID: 9887100
  35. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.
    Science. 1999 Apr 2;284(5411):156-9 PMID: 10102818
  36. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
    EMBO J. 1999 Apr 1;18(7):1805-14 PMID: 10202144
  37. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.
    EMBO J. 1999 Apr 1;18(7):1815-23 PMID: 10202145
  38. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity.
    Oncogene. 1999 May 27;18(21):3205-12 PMID: 10359526
  39. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.
    Genes Dev. 1999 Oct 1;13(19):2490-501 PMID: 10521394
  40. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction.
    Oncogene. 1999 Oct 21;18(43):5954-8 PMID: 10557083
  41. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
    Cancer Res. 1999 Dec 15;59(24):6046-51 PMID: 10626788
  42. Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase.
    Ann N Y Acad Sci. 1999;886:200-3 PMID: 10667219
  43. Stress signals utilize multiple pathways to stabilize p53.
    Mol Cell Biol. 2000 May;20(9):3224-33 PMID: 10757806
  44. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.
    J Biol Chem. 1990 Oct 5;265(28):17174-9 PMID: 2211619
  45. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  46. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Cell. 1992 Jun 26;69(7):1237-45 PMID: 1535557
  47. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  48. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
    Radiother Oncol. 1993 Jan;26(1):45-50 PMID: 8438086
  49. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  50. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.
    Nature. 1994 Jul 21;370(6486):220-3 PMID: 8028670
  51. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
    Mol Cell Biol. 1994 Sep;14(9):6264-77 PMID: 8065358
  52. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Cancer Res. 1994 Sep 15;54(18):4855-78 PMID: 8069852
  53. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
    Genes Dev. 1994 Dec 1;8(23):2817-30 PMID: 7995520
  54. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein.
    Mol Cell Biol. 1995 Feb;15(2):1060-70 PMID: 7823921
  55. Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
    Genes Dev. 1995 Sep 1;9(17):2170-83 PMID: 7657168
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2001-02-00
Pages
1297-310
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC99582
Subset
IM
Grants
NCI NIH HHS · P01 CA067166 · United States
NIEHS NIH HHS · R37 ES005777 · United States
NCI NIH HHS · CA67166 · United States
NIEHS NIH HHS · R01 ES005777 · United States
NCI NIH HHS · CA64489 · United States
NCI NIH HHS · R01 CA088480 · United States
NCI NIH HHS · R37 CA088480 · United States
NIEHS NIH HHS · ES05777 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com